The weak expression in endometrioid adenocarcinoma indicates that calretinin may not serve as a dependable diagnostic marker for endometrial cancers; however, its absence could assist in differentiating between certain benign and malignant conditions [27]. The gene discussed is CALB2; the disease is endometrial cancer.